PUBLISHER: The Business Research Company | PRODUCT CODE: 1563201
PUBLISHER: The Business Research Company | PRODUCT CODE: 1563201
Lyophilization, also known as freeze-drying, is a critical dehydration process used in the biopharmaceutical industry to preserve and stabilize sensitive biological products. These services involve specialized techniques for handling and processing pharmaceuticals such as proteins, vaccines and other biological materials. The primary goal is to remove water content while maintaining the structural and functional integrity of the products, which is essential for ensuring their efficacy and safety.
The lyophilization services for biopharmaceuticals market consists of sales, by entities (organizations, sole traders and partnerships), of various services such as contract services for custom development and manufacturing and packaging solutions to preserve product stability, associated with the lyophilization process.
The global lyophilization services for biopharmaceuticals market was valued at $1,028.12 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 9.0%.
Increased Demand For Vaccines And Antibodies
The increased demand for vaccines and antibodies drove the growth of lyophilization services for the biopharmaceuticals market during the historic period. Rising demand for vaccines and antibodies, especially COVID-19 vaccines, heightened the need for lyophilization to ensure product stability and transportability. By preserving sensitive biological compounds and enhancing shelf life, lyophilization enabled efficient storage and distribution. This growth in demand directly accelerated the expansion of lyophilization services to meet the biopharmaceutical sector's increasing production and quality requirements. For instance, according to the Global Vaccine Market Report 2022, published by the World Health Organization (WHO), the global vaccine market saw a dramatic increase in 2021, with approximately 16 billion doses worth $141 billion, nearly three times the 2019 volume and over three times its value. This surge, largely driven by COVID-19 vaccines, highlights the scalability of vaccine production in response to health emergencies. Despite increased manufacturing capacity, it remains concentrated, with ten companies supplying 70% of vaccine doses, excluding COVID-19 vaccines. Additionally, in June 2022, according to UmabsDB, a US-based comprehensive antibody therapeutics database, 162 antibody therapies were approved globally, with 122 in the USA, 114 in Europe, 82 in Japan and 73 in China. These approvals included 115 canonical antibodies, 14 antibody-drug conjugates, 7 bispecific antibodies, 8 antibody fragments, 3 radiolabeled antibodies, 1 antibody-conjugate immunotoxin, 2 immunoconjugates and 12 Fc-fusion proteins. Therefore, the increased demand for vaccines and antibodies supported the growth of lyophilization services in the biopharmaceuticals market.
Introduction Of Advanced Laboratory Freeze Dryers Enhancing Research Efficiency
Major players in the market are introducing advanced laboratory freeze dryers designed to enhance research efficiency. These cutting-edge instruments feature intuitive touch screens for precise parameter control and include automated functions such as auto-defrost and power restoration restart. Their versatility in accommodating various containers, like flasks and vials, supports diverse laboratory applications, optimizing workflow and expanding research capabilities. For example, in December 2023, VFL Sciences Private Limited, an India-based advanced instruments, consumables and reagents manufacturing company for scientific studies, introduced the Penguin Classic Laboratory Freeze Dryer and Lyophilizer, designed for ease of use on a lab bench. This state-of-the-art instrument features a 7" touch screen for easy parameter programming and includes functions such as auto defrost and auto restart after power restoration. It offers flexibility in accommodating various containers like flasks, vials and petri dishes, enhancing its utility for diverse laboratory applications.
The global lyophilization services for biopharmaceuticals market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 24.64% of the total market in 2023.
Lyophilization Services For Biopharmaceuticals Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global lyophilization services for biopharmaceuticals market as it emerges from the COVID-19 shut down.
Where is the largest and fastest-growing market for lyophilization services for biopharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The lyophilization services for biopharmaceuticals market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider lyophilization services for biopharmaceuticals market; and compares it with other markets.